Intuit Insider Sold Shares Worth $1,941,800, According to SEC Filing-February 2024-www.financetom.com

Intuit Insider Sold Shares Worth $1,941,800, According to SEC Filing

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Intuit Insider Sold Shares Worth $1,941,800, According to SEC Filing

Sep 22, 2024 8:42 PM

05:53 PM EDT, 09/19/2024 (MT Newswires) -- Eve B Burton, Director, on September 19, 2024, sold 2,988 shares in Intuit (INTU) for $1,941,800.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/896878/000158728924000002/xslF345X05/wk-form4_1726781499.xml

Price: 654.69, Change: +0.45, Percent Change: +0.07

Previous page： American Water Works Says Pennsylvania Court Dismisses Challenge to Wastewater Asset Acquisition Next page： Calidi Biotherapeutics Says FDA Clears Phase 1b/2 Trial of CLD-101 in High-Grade Glioma

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

American Water Works Says Pennsylvania Court Dismisses Challenge to Wastewater Asset Acquisition

Oct 2, 2024

09:02 AM EDT, 09/30/2024 (MT Newswires) -- American Water Works ( AWK ) said Friday the Pennsylvania Commonwealth Court has dismissed appeals challenging the Pennsylvania Public Utility Commission's approval of its $230 million acquisition of Butler Area Sewer Authority's wastewater assets. Following the court decision, American Water Works ( AWK ) said its subsidiary Pennsylvania-American Water will move forward to...

Calidi Biotherapeutics Says FDA Clears Phase 1b/2 Trial of CLD-101 in High-Grade Glioma

Oct 2, 2024

09:02 AM EDT, 09/30/2024 (MT Newswires) -- Calidi Biotherapeutics ( CLDI/WS ) said Monday that the US Food and Drug Administration has cleared Northwestern University's investigational new drug application for the company's CLD-101 therapy, which uses stem cells to deliver engineered oncolytic adenoviruses. A phase 1b/2 trial of the investigational treatment is expected to begin late this year at the...

Sector Update: Consumer Stocks Steady Pre-Bell Monday

Oct 2, 2024

09:03 AM EDT, 09/30/2024 (MT Newswires) -- Consumer stocks were steady pre-bell Monday with the Consumer Staples Select Sector SPDR Fund ( XLP ) and Consumer Discretionary Select Sector SPDR Fund ( XLY ) recently inactive. Yunji ( YJ ) shares were up over 15% after the company regained compliance with Nasdaq's minimum bid price requirement for continued listing. Jack...

Osisko Gold Acquires Royalties on Dalgaranga Gold Project in Australia for $50 Million

Oct 2, 2024

09:03 AM EDT, 09/30/2024 (MT Newswires) -- Osisko Gold Royalties ( OR ) said on Monday that it had agreed to acquire a 1.8% gross revenue royalty on the Dalgaranga Gold project in Western Australia, operated by Spartan Resources Limited The company said it also acquired a 1.35% gross revenue royalty on nearby exploration licenses to Dalgaranga. Osisko Gold Royalties...